Expanding screening through the use of liquid biopsy for early cancer detection
Screening programs have helped reduce cancer-specific mortality by detecting cancer at earlier stages. Developing increasingly sensitive, organ-specific liquid biopsy assays to evaluate tumor-derived analytes could pave the way for non-invasive early cancer diagnosis in population screening programs. Perachino et al. discuss screening through the use of liquid biopsy for early cancer detection. They emphasize the need for exceptionally high sensitivity and specificity when implementing such programs in the general population.
Authors
- Marta Perachino (ORCID: https://orcid.org/0000-0001-7115-120X)
- Javier Carmona (ORCID: https://orcid.org/0000-0003-1281-301X)
- Carolina Ortiz (ORCID: https://orcid.org/0000-0002-5523-829X)
- Ana P. Vivancos (ORCID: https://orcid.org/0000-0003-2888-6512)
- Cristina Saura (ORCID: https://orcid.org/0000-0001-8296-5065)
Institutions
- Hebron University (PS)
- Vall d'Hebron Institut de Recerca (ES)
- Vall d'Hebron Hospital Universitari (ES)
- Vall d'Hebron Institute of Oncology (ES)
Publication Details
- Journal
- Communications Medicine
- Published
- 2025-05-10
- DOI
- https://doi.org/10.1038/s43856-025-00885-9
- Citations
- 7
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 6.55